Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-07

Clinical Trial Update: Assessment of the Therapeutic Efficacy and Tolerability of the Artesunate/Amodiaquina Combination and Artemether/Lumefantrine Combination, Treatment of Uncomplicated P. Falciparum Malaria in the Department of Chocó (Colombia) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing artesunate/amodiaquine vs artemether/lumefantrine for uncomplicated Plasmodium falciparum malaria with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Artesunate-amodiaquine (artesunate-amodiaquine)

Snippet

Sponsor: Universidad Nacional de Colombia | Conditions: P. Falciparum Malaria | Phase 4 | Status: COMPLETED